Effect of maternal administration of thyrotropin-releasing hormone or DN1417 on functional and morphologic fetal rabbit lung maturation and duration of survival after premature delivery.
Though maternal treatment with thyrotropin-releasing hormone (TRH) for prevention of hyaline membrane disease has been utilized, precise mechanisms of TRH in accelerating fetal lung maturation remain unclear. We studied the effect of maternally administered TRH or DN1417 (an analog of TRH) on functional and morphologic fetal rabbit lung maturation and the duration of survival after premature delivery. Because DN1417 retains the neurotransmitter but not the neuroendocrine effects of TRH, this study enables us to determine which of these effects was responsible for enhancement of lung maturation. TRH or DN1417 (0.2 mg/kg/dose) or saline was injected intravenously into New Zealand White rabbit does 48, 36, 24, 12 and 2 h prior to sacrifice on day 27 of gestation. Functional pulmonary maturity was assessed by pressure-volume hysteresis, and morphologic maturity was assessed by histologic technique. Maternal administration of TRH or DN1417 enhanced both functional and morphologic fetal lung maturation as well as the duration of neonatal survival after premature delivery. We propose that the effect of TRH in fetal lung maturation is due to neurotransmitter rather than neuroendocrine effects.
Devaskar
U P
UP
Department of Pediatrics and Pathology, St. Louis University School of Medicine, Cardinal Glennon Children's Hospital, Mo.
deMello
D E
DE
Ackerman
J
J
D000818:Animals; D005260:Female; D005325:Fetal Organ Maturity / Q000187:drug effects*; D005328:Fetal Viability / Q000187:drug effects; D005865:Gestational Age; D006728:Hormones / Q000494:pharmacology; D008168:Lung / Q000196:embryology*; D008431:Maternal-Fetal Exchange; D011247:Pregnancy; D011817:Rabbits; D013973:Thyrotropin-Releasing Hormone / Q000031:analogs & derivatives* / Q000494:pharmacology*
D006728:Hormones; D013973:Thyrotropin-Releasing Hormone; C029762:DN 1417